Detalles de la búsqueda
1.
National registry of hemoglobinopathies in Greece: updated demographics, current trends in affected births, and causes of mortality.
Ann Hematol
; 98(1): 55-66, 2019 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-30196444
2.
Real-world data on Len/Dex combination at second-line therapy of multiple myeloma: treatment at biochemical relapse is a significant prognostic factor for progression-free survival.
Ann Hematol
; 97(9): 1671-1682, 2018 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-29756171
3.
Correction to: Real-world data on Len/Dex combination at second-line therapy of multiple myeloma: treatment at biochemical relapse is a significant prognostic factor for progression-free survival.
Ann Hematol
; 97(9): 1747, 2018 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-29943159
4.
A national registry of haemoglobinopathies in Greece: deducted demographics, trends in mortality and affected births.
Ann Hematol
; 91(9): 1451-8, 2012 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-22526366
5.
The prognostic significance of chromosome 17 abnormalities in patients with myelodysplastic syndrome treated with 5-azacytidine: Results from the Hellenic 5-azacytidine registry.
Cancer Med
; 8(5): 2056-2063, 2019 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-30897290
6.
Myelodysplastic neoplasm with isolated thrombocytopenia and immune thrombocytopenic purpura in adults: insights from a comparison of two national registries.
Leukemia
; 37(3): 708-711, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36646886
7.
Refinement of prognosis and the effect of azacitidine in intermediate-risk myelodysplastic syndromes.
Blood Cancer J
; 11(2): 30, 2021 02 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-33574231
Resultados
1 -
7
de 7
1
Próxima >
>>